|
ISIN No
|
INE168P01015
|
BSE Code / NSE Code
|
544210 / EMCURE
|
Book Value (Rs.)
|
262.35
|
Face Value
|
10.00
|
|
Bookclosure
|
14/08/2025
|
52Week High
|
1672
|
EPS
|
35.94
|
P/E
|
45.73
|
|
Market Cap.
|
31155.25 Cr.
|
52Week Low
|
916
|
P/BV / Div Yield (%)
|
6.26 / 0.18
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2503 |
Emcure Pharma UK Ltd.
| Equity Share | Subsidiary | 311.01 |
| 2503 |
Marcan Pharmaceuticals Inc.
| Equity Share | Subsidiary | 252.54 |
| 2503 |
Emcure Pharmaceuticals Mena FZ-LLC
| Equity Share | Subsidiary | 32.24 |
| 2503 |
ABCD Technologies LLP
| Equity Share | Partnership Firm | 25.00 |
| 2503 |
Emcure Pharmaceuticals South Africa (Pty) Ltd.
| Equity Share | Subsidiary | 17.88 |
| 2503 |
Emcure Brasil Formaceutica LTDA
| Equity Share | Subsidiary | 12.26 |
| 2503 |
Zuventus Healthcare Ltd.
| Equity Share | Subsidiary | 7.37 |
| 2503 |
Gennovo Biopharmaceuticals Ltd.
| Equity Share | Subsidiary | 5.34 |
|